Medidata Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MDSO and buy or sell other stocks, ETFs, and their options commission-free!

About MDSO

Medidata Solutions, Inc. engages in provision of cloud based solutions for life sciences. It offers advanced analytics, data capture and management, trial management, patient cloud and trial planning. 

CEO
Anthony Costello
CEOAnthony Costello
Employees
—
Employees—
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1999
Founded1999
Employees
—
Employees—

MDSO Key Statistics

Market cap
5.76B
Market cap5.76B
Price-Earnings ratio
129.38
Price-Earnings ratio129.38
Dividend yield
—
Dividend yield—
Average volume
1.54M
Average volume1.54M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$98.60
52 Week high$98.60
52 Week low
$60.10
52 Week low$60.10

Stock Snapshot

Medidata Solutions(MDSO) stock is priced at $92.22, giving the company a market capitalization of 5.76B. It carries a P/E multiple of 129.38.

On 2026-11-12, Medidata Solutions(MDSO) stock opened at —, reached a high of —, and a low of —.

Medidata Solutions(MDSO) shares are trading with a volume of 0, against a daily average of 1.54M.

In the last year, Medidata Solutions(MDSO) shares hit a 52-week high of $98.60 and a 52-week low of $60.10.

In the last year, Medidata Solutions(MDSO) shares hit a 52-week high of $98.60 and a 52-week low of $60.10.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.